Microdosing goes mainstream

Dana Smith, a freelance science journalist, shares her insights on the rising trend of microdosing psychedelics as a means to boost mood and enhance performance. She discusses compelling personal stories of individuals using small doses to alleviate anxiety and depression. The conversation dives into educational settings where microdosing has improved focus in classrooms. Smith also addresses the legislative landscape, including Oregon's psilocybin legalization, and the economic potential of the psychedelics market, questioning the ethics of these emerging therapies.